SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-052015
Filing Date
2018-08-14
Accepted
2018-08-14 17:21:35
Documents
80
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-14061_110q.htm 10-Q 962119
2 EX-10.2 a18-14061_1ex10d2.htm EX-10.2 129649
3 EX-31.1 a18-14061_1ex31d1.htm EX-31.1 10852
4 EX-31.2 a18-14061_1ex31d2.htm EX-31.2 10802
5 EX-32.1 a18-14061_1ex32d1.htm EX-32.1 5731
6 EX-32.2 a18-14061_1ex32d2.htm EX-32.2 6155
13 GRAPHIC g140611gai001.gif GRAPHIC 73364
  Complete submission text file 0001104659-18-052015.txt   6033746

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ontx-20180630.xml EX-101.INS 1243720
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ontx-20180630.xsd EX-101.SCH 70226
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ontx-20180630_cal.xml EX-101.CAL 39151
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ontx-20180630_def.xml EX-101.DEF 242817
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ontx-20180630_lab.xml EX-101.LAB 507276
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ontx-20180630_pre.xml EX-101.PRE 411753
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 181018936
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1